| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.33 | 0.06 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.07 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |